October 2021
221 articles-
Oct 29 · 05:44Biotechnology Daily
Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform
-
Oct 29 · 05:41Biotechnology Daily
Biotech founder, MIT researcher Sabatini alleges sexual harassment claims against him are false
-
Oct 29 · 05:39Biotechnology Daily
Medtronic taps TikTok-famous physician as first chief medical officer of GI business
-
Oct 29 · 05:37Biotechnology Daily
Ocular's insert for dry eye disease misses primary endpoint in phase 2 trial
-
Oct 29 · 05:34Bio Business News
Juventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful
-
Oct 29 · 05:32Bio Business News
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession
-
Oct 29 · 05:30Bio Business News
Cedilla tops off series B with additional $25M to test drugs in mesothelioma, certain breast cancers
-
-
Oct 29 · 04:57Market Watch
Ether hits record high at $4,400 as crypto surge continues
-
Oct 29 · 04:46Market Watch
Gold futures reclaim the $1,800-an-ounce mark
-
Oct 28 · 05:39Biotechnology Daily
Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue
-
Oct 28 · 05:37Biotechnology Daily
Could cancer drugs address a hard-to-treat lung disease? Researchers say 2 look promising
-
Oct 28 · 05:36Biotechnology Daily
VCs back Leucid to trial CAR-T twist in ovarian cancer patients
-
Oct 28 · 05:35Biotechnology Daily
FDA approves Luminopia's VR-based digital therapeutic which treats lazy eye with TV time
-
Oct 28 · 05:33Bio Business News
Athira CEO Kawas officially out after investigation found she did alter grad research
-
Oct 28 · 05:32Bio Business News
Agenus withdraws cervical cancer application, and a behind the scenes David vs. Big Pharma regulatory battle is revealed
-
Oct 28 · 05:05Bio Business News
Zerigo Health beams up $43M from Bayer, Cigna and more for at-home psoriasis UV light therapy
-
Oct 28 · 05:02Bio Business News
Ventyx nabs a $152M upsized IPO to challenge BMS' Zeposia—and a backer with intimate knowledge of its rival
-
Oct 28 · 00:10Market Watch
Tesla stock closes at record on the heels of Uber-Hertz deal
-
Oct 28 · 00:08Market Watch
KLA stock rises as earnings, outlook top Street view
-
Oct 28 · 00:06Market Watch
Coal returns from the dead to power the world as renewables fall short
-
Oct 27 · 14:22Biotechnology Daily
Princeton and MIT gene-editing pioneers uncover clues for improving CRISPR and other tools
-
Oct 27 · 14:19Biotechnology Daily
Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA
-
Oct 27 · 14:17Biotechnology Daily
NYU surgeons successfully transplant kidney from genetically modified pig into human patient